SG/PUT/PFIZER INC/35/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 15:43:19 2024-06-21 EDT | ||
| 0.72 EUR | +2.86% |
|
| Current month | +20.00% | ||
| 1 month | +22.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-06-21 | 0.72 | +2.86% |
| 24-06-20 | 0.7 | -4.11% |
| 24-06-19 | 0.73 | 0.00% |
| 24-06-18 | 0.73 | -3.95% |
| 24-06-17 | 0.76 | +7.04% |
Delayed Quote Deutsche Boerse AG
Last update June 21, 2024 at 03:43 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| WKN | SV6QZL |
| ISIN | DE000SV6QZL9 |
| Date issued | 2023-05-24 |
| Strike | 35 $ |
| Maturity | 2024-09-20 (91 Days) |
| Parity | 10 : 1 |
| Emission price | 0.25 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.94 € |
|---|---|
| Lowest since issue | 0.18 € |
| Spread | 0.01 € |
| Spread % | 1.39% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.74
USD
Average target price
31.92
USD
Spread / Average Target
+15.05%
- Stock Market
- Warrants
- Warrant
